Company Filing History:
Years Active: 1998-2003
Title: Innovations of Catherine R Ferenz
Introduction
Catherine R Ferenz is a notable inventor based in Belchertown, MA (US). She has made significant contributions to the field of biochemistry, particularly through her work on interleukin-1β converting enzyme (ICE). With a total of four patents to her name, her innovations have the potential to impact various applications in medical research and drug development.
Latest Patents
Catherine's latest patents focus on modified forms of human interleukin-1β converting enzyme that exhibit increased stability compared to unmodified versions. These modified enzymes display proteolytic activity and include nucleic acid molecules encoding a modified p10 subunit of ICE. Additionally, recombinant vectors and host cells that incorporate these nucleic acid molecules are also part of her innovations. The modified ICE protein can cleave ICE substrates and identify modulators of ICE activity in screening assays. Due to its enhanced stability, this modified ICE is particularly suitable for preparing ICE crystals for X-ray crystallography.
Career Highlights
Throughout her career, Catherine has worked with prominent companies such as BASF Aktiengesellschaft. Her experience in these organizations has contributed to her expertise in the field and has allowed her to develop her innovative ideas further.
Collaborations
Catherine has collaborated with notable individuals in her field, including John A Mankovich and Robert V Talanian. These collaborations have likely enriched her research and contributed to her success as an inventor.
Conclusion
Catherine R Ferenz is a distinguished inventor whose work on modified interleukin-1β converting enzyme has the potential to advance medical research significantly. Her contributions to the field are noteworthy and reflect her dedication to innovation.